Captrust Financial Advisors Atrion Corp Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$605.0 - $763.25 $1,210 - $1,526	-2 Reduced 1.69%	116 $73,000
Q2 2022 Aug 16, 2022	BUY	$605.0 - $763.25 $1,210 - $1,526	2 Added 1.72%	118 $74,000
Q1 2022 May 16, 2022	SELL	$601.4 - $763.0 $119,678 - $151,837	-199 Reduced 63.17%	116 $83,000
Q4 2021 Feb 14, 2022	BUY	$650.15 - $802.0 $146,933 - $181,252	226 Added 253.93%	315 $222,000
Q3 2021 Nov 16, 2021	BUY	$594.24 - $758.0 $47,539 - $60,640	80 Added 888.89%	89 $62,000
Q1 2021 May 17, 2021	BUY	$619.2 - $736.0 $5,572 - $6,624	9 New	9 $6,000

114K

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.